UBS Group’s Cartesian, Inc. CRTN Stock Holding History

UBS Group’s Portfolio CRTN Stock Details CRTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,327	Closed	-$3K	–	8396
2017 Q3	$3K	Buy	+4,327	New	+$2.81K	﹤0.01%	7440
2017 Q2	–	Sell	-2,474	Closed	-$2K	–	8298
2017 Q1	$2K	Sell	2,474 -3,840	-61%	-$4.32K	﹤0.01%	7358
2016 Q4	$6K	Buy	+6,314	New	+$4.42K	﹤0.01%	7195
2015 Q4	–	Sell	-5,073	Closed	-$12K	–	8754
2015 Q3	$12K	Buy	5,073 +672	+15%	+$1.94K	﹤0.01%	7167
2015 Q2	$15K	Buy	4,401 +2,391	+119%	+$8.26K	﹤0.01%	7150
2015 Q1	$7K	Buy	2,010 +1,163	+137%	+$4.47K	﹤0.01%	7958
2014 Q4	$4K	Buy	+847	New	+$3.45K	﹤0.01%	9163

Other funds holding CRTN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

UBS Group's CRTN Position: Q4 2017 in Review

UBS Group sold out of Cartesian, Inc. (CRTN) in Q4 2017, closing a stake of 4,327 shares — an estimated $3K sold.

UBS Group first reported a position in CRTN in Q4 2014 and held it in 7 quarters. The position peaked at $15K in Q2 2015. 1 fund tracked by Wall St. Rank holds CRTN as of Q4 2017.

UBS Group reported no remaining Cartesian, Inc. position as of Q4 2017 after selling out during the quarter.
UBS Group sold 4,327 Cartesian, Inc. shares in Q4 2017, an estimated $3K.
UBS Group first reported a position in Cartesian, Inc. in Q4 2014 and held it in 7 quarters.
UBS Group's Cartesian, Inc. position peaked at $15K in Q2 2015.
1 fund tracked by Wall St. Rank held Cartesian, Inc. as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.